Open Nav

Martin Philips

CEO

Opsidio

Martin has over 30 years of experience developing numerous antibody and small molecule drugs as CMO of two venture-funded biotechs, and as VP of Clinical Research of Aventis Behring. He is a Board-certified Hematologist and had faculty positions at University of Texas and Baylor College of Medicine. Martin has experience in all phases of drug development and regulatory agency interactions. He is an angel investor, advisor to several biotechs, and serves on philanthropic boards.

This speaker's sessions:

Back